Playback speed
10 seconds
Frontline Ibrutinib + Venetoclax Combination for CLL/SLL Leads to High Rates of Undetectable MRD: Results from the CAPTIVATE Study
668 views
March 25, 2020
Login to view comments.
Click here to Login